Viewing Study NCT05622058

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-02-27 @ 10:01 AM
Study NCT ID: NCT05622058
Status: TERMINATED
Last Update Posted: 2023-02-27
First Post: 2022-06-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer
Sponsor: Aileron Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prevention of Chemotherapy-induced Myelosuppression View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ALRN-6924 View
None Chemoprotection View
None Myelosuppression View
None Cell cycle arrest View
None p53 mutation View
None Breast cancer View
None Alopecia View
None Neutropenia View